GENE ONLINE|News &
Opinion
Blog

Roche
GeneOnline’s Top Mergers and Acquisitions of 2019
2019-12-31
Comprehensive Genomic Profiling at the Cusp of Modern Precision Oncology: Interview with Dr. Nicolas Martin 
2019-12-03
Rozlytrek Becomes the Third Tumor-Agnostic Medicine to be Approved by the USFDA
2019-08-21
Weekly in Asia 20190616-0622
2019-06-27
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
1 4 5 6
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top